Ritalin is a common drug found in homes with kids with ADHD.
But because it's a stimulant, many parents don't want their children to use it.
NBC's Diana Gonzalez tells us about a different type of drug that's being viewed as an alternate therapy.
|
More Info on Study
- Miami Research Associates
305-665 2985
|
Atomoxetine is the new non-stimulant drug under FDA review as a treatment for ADHD. Dr. Richard Rubin is involved in the clinical trials.
"This new medicine really develops a different kind of chemistry for use with kids," he says.
Ritalin works by increasing dopamine, a chemical that helps trasmit messages in the brain. Atomoxetine targets a different chemical, and there is another important difference.
Dr. Rubin says, "We're trying to have an alternative medicine that won't have abuse potential because this does not."
Ana Yanes' son has been involved in the study. He's taken Ritalin in the past, and she has seen a change.
"There is no change in mood swings at all with this medication," she says. "You don't see the effect that once the medicine wears off that their behavior changes drastically. You don't see that at all."
The study is currently underway for children ages 8 to 12. In April, a new study begins for children age 6 to 16 and adults age 18 to 50. Here's what participants have told Dr. Rubin:
"I feel like myself. I don't feel different than my usual style or personality. Parents notice that, that the kids are themselves when they are on the medicine. They are just maybe paying attention more, they are calmer with their behavior. They can control themselves to get through the activity better."
For a number to call for more information, see the box above.
March 6, 2002
